NOMENCLATURE OF BLOOD
A committee for clarification of the nomenclature of cells and diseases of the blood and blood-forming organs sponsored by the American Society of Clinical Pathologists and the American Medical Association has been functioning since October 1947.1 The chairman is Dr. Edwin E. Osgood, chief of the Division of Experimental Medicine at the University of Oregon Medical School. The membership is composed of outstanding hematologists from all sections of the United States, including special representatives of the sponsoring societies. The committee has held three meetings, two in Chicago and one in San Francisco, and plans a fourth meeting in Buffalo during August. It has been agreed that the choice of preferred terms will not be based merely on historical priority or common usage but in general, should represent the simplest, clearest and most descriptive term possible. Consistency between related terms is considered essential. The committee has given
Current Comment. JAMA. 1948;137(18):1605. doi:10.1001/jama.1948.02890520037016
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: